Cargando…
Letter to the Editor in Response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)"
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146672/ https://www.ncbi.nlm.nih.gov/pubmed/32344369 http://dx.doi.org/10.1016/j.dsx.2020.04.002 |
| _version_ | 1783520255359844352 |
|---|---|
| author | Home, Philip |
| author_facet | Home, Philip |
| author_sort | Home, Philip |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7146672 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Diabetes India. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71466722020-04-10 Letter to the Editor in Response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)" Home, Philip Diabetes Metab Syndr Letter to the Editor Diabetes India. Published by Elsevier Ltd. 2020 2020-04-10 /pmc/articles/PMC7146672/ /pubmed/32344369 http://dx.doi.org/10.1016/j.dsx.2020.04.002 Text en © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Home, Philip Letter to the Editor in Response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)" |
| title | Letter to the Editor in Response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)" |
| title_full | Letter to the Editor in Response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)" |
| title_fullStr | Letter to the Editor in Response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)" |
| title_full_unstemmed | Letter to the Editor in Response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)" |
| title_short | Letter to the Editor in Response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.)" |
| title_sort | letter to the editor in response to article: "clinical considerations for patients with diabetes in times of covid-19 epidemic (gupta et al.)" |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146672/ https://www.ncbi.nlm.nih.gov/pubmed/32344369 http://dx.doi.org/10.1016/j.dsx.2020.04.002 |
| work_keys_str_mv | AT homephilip lettertotheeditorinresponsetoarticleclinicalconsiderationsforpatientswithdiabetesintimesofcovid19epidemicguptaetal |